Summary
In order to investigate the effect of curcumin on proliferation and apoptosis of human pterygium fibroblasts (HPF) in culture and search for a new method to prevent the recurrence after pterygium surgery, HPF was incubated with 0–160 μmol/L curcumin for 24–96 h. The MTT method was used to assay the biologic activities of curcumin at different time points and different doses. The expression of proliferating cell nuclear antigen (PCNA) in each group was detected by immunohistochemistry. The cell cycle distribution was detected by flow cytometry (FCM). Administration of 20–80 μmol/L curcumin for 24–72 h could significantly inhibit HPF proliferation in a dose-and time-dependent manner (P<0.05). After treatment with curcumin at different concentrations of 20, 40, 80 and 160 μmol/L for 24 h, FCM revealed there was a significant sub-G1 peak at each concentration. The number of HPF in G0/G1 phase was increased, while in S phase, it was decreased (P<0.05). At the concentration of 20–80 μmol/L, curcumin, in a dose-dependent manner (P<0.05), could inhibit the expression of PCNA in HPF. It was suggesterd that curcumin could significantly inhibit the proliferation of HPF, make HPF arrest in G0/G1 phase and induce the apoptosis of HPF in a dose-and time-dependent manner.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Araujo C C, Leon L L. Biological activities of curcuma longa L. Mem Inst Oswaldo Cruz, 2001,96(5):723–728
Busquets S, Carbo N, Almendro V et al. Curcumin, a natural product present in tumeric, decreases tumor growth but does not be have as an anticachectic compound in a rat model. Cancer Lett, 2001,167(1):33–38
Prusty B K, Das B C. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer, 2005,113(6):951–960
Bharti A C, Donato N, Aggarwal B B. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-indu cible STAT3 phosphorylation in human multiple myeloma cells. J Immunol, 2003,171(7):3863–3871
Nolan T M, Di Girolamo N, Coroneo M T et al. Proliferative effects of heparin-binding epidermal growth factor-like growth factor on pterygium epithelial cells and fibroblasts. Invest Ophthalmol Vis Sci, 2004,45(1):110–113
Coroneo M T, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol, 1999,10(4):282–288
Tan D T, Chee S P, Dear K B et al. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol, 1997,115(10):1235–1240
Surh Y J, Chun K S, Cha H H et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res, 2001,480–481:243–268
Moragoda L, Jaszewski R, Majumdar A P. Curcumin induces modulation of cell cycle and apoptosis in gastric and colon cancer cells. Anticancer Res, 2001, 21(2A):873–878
Ohta Y, Ichimura K. Proliferation markers, proliferating cell nuclear antigen, Ki67, 5-bromo-2’-deoxyuridine, and cyclin D1 in mouse olfactory epithelium. Ann Otol Rhinol Laryngol, 2000,109(11):1046–1048
Author information
Authors and Affiliations
Additional information
ZHANG Mingchang, male, born in 1961, Professor
Rights and permissions
About this article
Cite this article
Zhang, M., Bian, F., Wen, C. et al. Inhibitory effect of curcumin on proliferation of human pterygium fibroblasts. J. Huazhong Univ. Sc. Technol. 27, 339–342 (2007). https://doi.org/10.1007/s11596-007-0332-6
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11596-007-0332-6